Pine River Capital Management’s Pfizer PFE Stock Holding History

Pine River Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-459,333	Closed	-$14.6M	–	705
2015 Q2	$14.6M	Buy	+459,333	New	+$15M	0.16%	120
2015 Q1	–	Sell	-143,976	Closed	-$4.26M	–	754
2014 Q4	$4.26M	Sell	143,976 -14,335	-9%	-$411K	0.05%	223
2014 Q3	$4.44M	Buy	158,311 +70,829	+81%	+$1.99M	0.05%	298
2014 Q2	$2.46M	Sell	87,482 -457,014	-84%	-$13M	0.04%	333
2014 Q1	$16.6M	Sell	544,496 -214,068	-28%	-$6.38M	0.25%	101
2013 Q4	$22M	Sell	758,564 -365,949	-33%	-$10.7M	0.27%	107
2013 Q3	$30.6M	Buy	1,124,513 +331,483	+42%	+$9.02M	0.33%	66
2013 Q2	$21.1M	Buy	+793,030	New	+$21.9M	0.31%	80

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pine River Capital Management's PFE Position: Q4 2016 in Review

Pine River Capital Management sold out of Pfizer (PFE) in Q4 2016, closing a stake of 22,909 shares — an estimated $736K sold.

Pine River Capital Management first reported a position in PFE in Q2 2013 and held it in 12 quarters. The position peaked at $84M in Q3 2014. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

Pine River Capital Management reported no remaining Pfizer position as of Q4 2016 after selling out during the quarter.
Pine River Capital Management sold 22,909 Pfizer shares in Q4 2016, an estimated $736K.
Pine River Capital Management first reported a position in Pfizer in Q2 2013 and held it in 12 quarters.
Pine River Capital Management's Pfizer position peaked at $84M in Q3 2014.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Pine River Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.